Wintrust Financial Corporation Reports Third Quarter and Year-to-Date Results
ROSEMONT, Ill, Oct. 21, 2024 (GLOBE NEWSWIRE) — Wintrust Financial Corporation (“Wintrust”, “the Company”, “we” or “our”) (Nasdaq: WTFC) announced […]
MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly
Dallas, Texas, Oct. 21, 2024 (GLOBE NEWSWIRE) — Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on […]
Monroe Capital Corporation Schedules Third Quarter 2024 Earnings Release and Conference Call
CHICAGO, Oct. 21, 2024 (GLOBE NEWSWIRE) — Monroe Capital Corporation (the “Company”) (NASDAQ: MRCC) announced today that it will report […]
Chicago Atlantic BDC, Inc. Schedules Third Quarter 2024 Financial Results Conference Call
NEW YORK, Oct. 21, 2024 (GLOBE NEWSWIRE) — Chicago Atlantic BDC, Inc. (“Chicago Atlantic BDC” or the “Company”) (NASDAQ: LIEN), a […]
Marex Group plc Announces Launch of a Public Offering
NEW YORK, Oct. 21, 2024 (GLOBE NEWSWIRE) — Marex Group plc (Nasdaq: MRX) (“Marex”), the diversified global financial services platform, […]
Vision Sensing Acquisition Corp. Announces Delisting and Subsequent Liquidation
NEW YORK, Oct. 21, 2024 (GLOBE NEWSWIRE) — Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “Company” or “VSAC”), […]
Travere Therapeutics to Report Third Quarter 2024 Financial Results
SAN DIEGO, Oct. 21, 2024 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report third quarter […]
First Advantage and Sterling Announce Election Deadline for Sterling Stockholders to Elect Merger Consideration
ATLANTA and INDEPENDENCE, Ohio, Oct. 21, 2024 (GLOBE NEWSWIRE) — First Advantage Corporation (NASDAQ:FA) and Sterling Check Corp. (NASDAQ:STER) today […]
Editas Medicine and Genevant Sciences to Collaborate to Develop Novel mRNA-LNP Gene Editing Therapeutics
CAMBRIDGE, Mass. and VANCOUVER, British Columbia and BASEL, Switzerland, Oct. 21, 2024 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a […]
Rule 8 Announcement to Stockholders
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION […]
